ENISTRA Trademark
Trademark Overview
On Tuesday, September 3, 2002, a trademark application was filed for ENISTRA with the United States Patent and Trademark Office. The USPTO has given the ENISTRA trademark a serial number of 78160233. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, January 2, 2004. This trademark is owned by Pfizer Inc.. The ENISTRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, bacterial disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue repair preparations, dermatological preparations, gynecological preparations.
General Information
| Serial Number | 78160233 |
| Word Mark | ENISTRA |
| Filing Date | Tuesday, September 3, 2002 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, January 2, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 8, 2003 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, bacterial disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue repair preparations, dermatological preparations, gynecological preparations. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 17, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 26, 2004 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, May 20, 2004 | CASE FILE IN TICRS |
| Tuesday, July 1, 2003 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 8, 2003 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 19, 2003 | NOTICE OF PUBLICATION |
| Monday, January 27, 2003 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2003 | ASSIGNED TO EXAMINER |
